DROXIDOPA
NDC 68180-989, DROXIDOPA, capsule, from Lupin Pharmaceuticals, Inc..
- Product NDC
- 68180-989
- Status
- Listed
- Labeler
- Lupin Pharmaceuticals, Inc.
- Dosage form
- CAPSULE
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA211652
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/68180-989 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- DROXIDOPA300 mg/1
Pharmacologic classes
Catecholamines [CS]; Increased Blood Pressure [PE]
| Package NDC | NDC-11 | Package |
|---|
Linked data
RxNorm, label and prices
RxNorm concepts
RxNorm links no concept to this product's packages.
Related lookups
FDA label sections
GET /v1/drugs/labels/81b798dc-b8dc-48a5-af46-82bb55f789a8
Use it
Look up 68180-989 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/68180-989 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 68180-989. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.